USANA Health Sciences (USNA) Tops Q3 EPS by 6c

USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $0.97, $0.06 better than the analyst estimate of $0.91. Revenue for the quarter came in at $261.8 million versus the consensus estimate of $259.47 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c